Neurotoxin-induced animal model of multiple sclerosis: Molecular mechanism focus

被引:0
|
作者
Permana, Yandi [1 ]
Siswanto, Soni [2 ]
Aziz, Nur Hidayah Kaz Abdul [3 ]
Wardhani, Bantari Wisynu Kusuma [1 ,4 ]
机构
[1] Republ Indonesia Def Univ, Fac Mil Pharm, Bogor, West Java, Indonesia
[2] Univ Gadjah Mada, Fac Pharm, Yogyakarta, Indonesia
[3] Univ Sains Malaysia, Sch Pharmaceut Sci, George Town, Malaysia
[4] Natl Res & Innovat Agcy BRIN, Res Ctr Pharmaceut Ingredients & Tradit Med, Bogor, West Java, Indonesia
来源
PHARMACY EDUCATION | 2024年 / 24卷 / 06期
关键词
Animal model; Multiple sclerosis; Myelin essential protein; Myelin oligodendrocyte glycoprotein; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; INDUCED RAT MODEL; ETHIDIUM-BROMIDE; PRIMARY DEMYELINATION; TRANSGENIC MICE; CLINICAL-COURSE; REMYELINATION; NEUROINFLAMMATION; LYSOLECITHIN;
D O I
10.46542/pe.2024.246.7389
中图分类号
G40 [教育学];
学科分类号
040101 ; 120403 ;
摘要
Background: Neurotoxins can alter the central nervous system. They induce severe clinical symptoms such as encephalopathy, convulsions, muscle paralysis, and respiratory failure. Hence, the neurotoxin can mimic human central nervous system disorders such as Multiple Sclerosis (MS) to study pathophysiology and drugs of development. Objective: This mini-review compared the neurotoxins for mimicking MS in animal models. Method: This study was a narrative review using the scientific electronic databases Scopus, PubMed, and Google Scholar. All related articles by keywords animal models, multiple sclerosis, and neurotoxins were collected by YP and BW. All authors contributed to manuscript development. Result: Cuprizone, ethidium bromide, lysolecith in, Myelin Oligodendrocyte Glycoprotein (MOG), and Myelin Essential Protein (MBP) are neurotoxins for MS animal models. Cuprizone is particularly relevant for use in studies addressing toxic mechanisms of the demyelination process and studies of therapeutic interventions. Ethidium bromide causes spinal cord demyelination with distinctive features in the oligodendrocytes and astrocytes. However, it is a carcinogen agent. Lysolecithin is suitable for old animal models because the duration for remyelination is relatively longer than others. MOG and MBP are preferable to resemble MS pathophysiology in humans. Conclusion: MOG and MBP are appropriate for generating animal multiple sclerosis models for further in vivo experiments.
引用
收藏
页码:73 / 89
页数:17
相关论文
共 50 条
  • [41] Activation of Calpain and Caspase Pathways in Demyelination and Neurodegeneration in Animal Model of Multiple Sclerosis
    Das, Arabinda
    Guyton, M. Kelly
    Butler, Jonathan T.
    Ray, Swapan K.
    Banik, Naren L.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2008, 7 (03) : 313 - 320
  • [42] Humoral immunity in multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis
    Anne H. Cross
    Jennifer L. Stark
    Immunologic Research, 2005, 32 : 85 - 97
  • [43] mCSF-Induced Microglial Activation Prevents Myelin Loss and Promotes Its Repair in a Mouse Model of Multiple Sclerosis
    Laflamme, Nathalie
    Cisbani, Giulia
    Prefontaine, Paul
    Srour, Younes
    Bernier, Jordan
    St-Pierre, Marie-Kim
    Tremblay, Marie-Eve
    Rivest, Serge
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2018, 12
  • [44] Cognitive impairment in an animal model of multiple sclerosis and its amelioration by glatiramer acetate
    Aharoni, Rina
    Schottlender, Nofar
    Bar-Lev, Dekel D.
    Eilam, Raya
    Sela, Michael
    Tsoory, Michael
    Arnon, Ruth
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [45] Inhibition of Notch signaling enhances tissue repair in an animal model of multiple sclerosis
    Jurynczyk, M
    Jurewicz, A
    Bielecki, B
    Raine, CS
    Selmaj, K
    JOURNAL OF NEUROIMMUNOLOGY, 2005, 170 (1-2) : 3 - 10
  • [46] Humoral immunity in multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis
    Cross, AH
    Stark, JL
    IMMUNOLOGIC RESEARCH, 2005, 32 (1-3) : 85 - 97
  • [47] The Anti-inflammatory Effect of Ginger Extract on the Animal Model of Multiple Sclerosis
    Kamankesh, Fatemeh
    Ganji, Ali
    Ghazavi, Ali
    Mosayebi, Ghasem
    IRANIAN JOURNAL OF IMMUNOLOGY, 2023, 20 (02) : 211 - 218
  • [48] In Vivo PET Imaging Demonstrates Diminished Microglial Activation After Fingolimod Treatment in an Animal Model of Multiple Sclerosis
    Airas, Laura
    Dickens, Alex M.
    Elo, Petri
    Marjamaki, Paivi
    Johansson, Jarkko
    Eskola, Olli
    Jones, Paul A.
    Trigg, William
    Solin, Olof
    Haaparanta-Solin, Merja
    Anthony, Daniel C.
    Rinne, Juha
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (02) : 305 - 310
  • [49] Systematic Understanding of Bioactive Lipids in Neuro-Immune Interactions: Lessons from an Animal Model of Multiple Sclerosis
    Kihara, Yasuyuki
    ROLE OF BIOACTIVE LIPIDS IN CANCER, INFLAMMATION AND RELATED DISEASES, 2019, 1161 : 133 - 148
  • [50] Locomotor and histological changes in a cuprizone-induced animal model of multiple sclerosis: comparison between alpha-tocopherol and fingolimod
    Mitra, Nilesh
    Gurdib Singh, Nermesh Singh
    Binti Wadingasafi, Nurul Ain
    Chellian, Jestin
    RESEARCH IN PHARMACEUTICAL SCIENCES, 2022, 17 (02) : 134 - 142